Penningtons Manches Cooper renews partnership with One Nucleus. Cambridge UK: 18 August 2026 Penningtons Manches Cooper has renewed its partnership with One Nucleus. The One Nucleus Partner Programme is tailor-made to meet the needs of the One Nucleus Members, the Partner and One Nucleus in delivering on its core remit of supporting innovation. Rachel Bradley, Partner at Penningtons Manches Cooper commented: "Our long-standing relationship with One Nucleus reflects our shared commitment to supporting the success of innovative life sciences businesses. We are pleased to renew our partnership and continue engaging with a community that is driving scientific and technological advances with real-world impact. One Nucleus provides an invaluable platform for connecting industry leaders, investors, advisers and entrepreneurs, and we are proud to contribute our sector knowledge and legal expertise to that network. We look forward to building on the strong relationships developed through the partnership and supporting members as they navigate their growth journeys." Tony Jones, CEO of One Nucleus expands further 'We are delighted to renew our long-standing collaboration with Penningtons Manches Cooper through the One Nucleus Partner Programme. A key part of our role is to signpost members to trusted advisors who can support them at critical stages of their growth, and this partnership helps create an environment where those conversations can take place, connecting our community to the firm's specialist expertise across intellectual property, corporate, and commercial law. In turn, it provides Penningtons Manches Cooper with ongoing opportunities to develop and deepen relationships with innovative life science organisations, while maintaining insight into their evolving needs and challenges," About Penningtons Manches Cooper Penningtons Manches Cooper is a leading UK and international law firm with a strong reputation in the life sciences, healthcare and technology sectors. The firm advises clients ranging from start-ups, spin-outs and investors to established multinational businesses on a full range of legal matters, including intellectual property, corporate transactions, commercial agreements, regulatory issues, employment and dispute resolution. Through its sector-focused approach and deep industry knowledge, the firm helps innovative organisations achieve their commercial objectives and navigate complex legal challenges. About One Nucleus One Nucleus's vision is to supercharge bio-innovation. Its mission is to inspire, inform, and implement by connecting bio-innovation leaders and their companies with knowledge, investment, and deal-flow opportunities in a capital-efficient way, supporting organisations from start-up through to exit. As a not-for-profit life science membership organisation, One Nucleus brings together stakeholders from across the sector to help them achieve their aspirations on the global stage. Media Contact Information:

Tech London Advocates FinTech & InsurTech open mic live Penningtons Manches Cooper Hosts Open Mic Event at FinTech Week London 2026 Law firm Penningtons Manches Cooper is set to host the Tech London Advocates FinTech & InsurTech Open Mic Live event during the upcoming FinTech Week London 2026. The event is part of the week-long series of activities focused on financial technology innovations in the UK capital. Original Source: https://www.penningtonslaw.com/events/tech-london-advocates-fintech-insurtech-open-mic-live/

Strategic partner hire boosts Penningtons Manches Cooper's medical negligence practice. By News desk Published On: 5 March 2026 Leading law firm Penningtons Manches Cooper is delighted to announce the appointment of Robert dransfield as a partner in its nationally recognised personal injury and medical negligence team. Based in the London office, he will focus on complex and high value medical negligence claims, further strengthening the firm's well established reputation in this area. Robert joins from Stewarts where he was a medical negligence partner between 2007 and 2025. He has particular expertise in major spinal cord injury and cauda equina syndrome claims, and is also very experienced in brain injury, oncology, infection and amputee claims, particularly those valued at in excess of £1 million. Widely respected by both clients and his peers, Robert is a specialist panel member of Action against Medical Accidents (AvMA), the UK charity for patient safety and justice, a Fellow of the Royal Society of Medicine, and an Association of Personal Injury Lawyers (APIL) practitioner. He is recommended by both Legal 500 and Chambers UK, where he is described as 'an exceptional individual' and 'a master tactician, always one step ahead'. Led by partner Philippa Luscombe, Penningtons Manches Cooper's team of over 40 personal injury and medical negligence specialists is known for a combination of high quality technical expertise and client focused service to individuals and their families across the UK. It consistently achieves band 1 rankings in both the leading legal directories and is also commended in The Times Best Law Firms list. For the 2025/26 financial year, the team is expecting to see a 10 per cent increase in turnover. Commenting on Robert's arrival, Philippa said: "This is an important strategic appointment as we look to further enhance the capability of our London medical negligence practice, particularly in high value work and the delivery of exceptional client care. "Robert is exactly the individual we hoped to find - not only because of his unquestionable expertise, but also his commitment to his clients and his thoughtful, meticulous approach. "He is an excellent fit for our team - in terms of his personality, technical ability and reputation - and we are thrilled to welcome him." Robert added: "It is a privilege to join such a well-regarded national practice. "My work will remain centred on advocating for clients who have suffered catastrophic injuries, with particular emphasis on complex cauda equina syndrome claims and life-changing brain and spinal cord injury cases. "Penningtons Manches Cooper has strong specialist teams in all my key areas of focus, and I have long been genuinely impressed by its reputation in the sector. "I have thoroughly enjoyed meeting the team so far and feel that the firm's collegiate and collaborative culture aligns extremely well with my own approach."